Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorMısırlıoğlu, Naile Fevziye
dc.contributor.authorOruçoğlu, Gülbahar Güler
dc.contributor.authorBıçakhan, Burcu
dc.contributor.authorKüçük, Suat Hayri
dc.contributor.authorHimmetoğlu, Şölen
dc.contributor.authorSayılı, Sena Baykara
dc.contributor.authorÖzen, Gülenay Defne
dc.contributor.authorUzun, Hafize
dc.date.accessioned2025-03-22T16:05:28Z
dc.date.available2025-03-22T16:05:28Z
dc.date.issued2025en_US
dc.identifier.citationMisirlioglu, N. F., Orucoglu, G. G., Bıcakhan, B., Kucuk, S. H., Himmetoglu, S., Sayili, S. B., Ozen, G. D., & Uzun, H. (2025). Evaluation of Thrombomodulin, Heart-Type Fatty-Acid-Binding Protein, Pentraxin-3 and Galectin-3 Levels in Patients with Myocardial Infarction, with and Without ST Segment Elevation. Journal of Clinical Medicine, 14(3), 1015. https://doi.org/10.3390/jcm14031015en_US
dc.identifier.issn2077-0383
dc.identifier.urihttps://hdl.handle.net/20.500.12900/624
dc.description.abstractBackground: Medical history, ECG findings and cardiac markers are used in the diagnosis of myocardial infarction (MI). Biomarkers used especially for the diagnosis of MI include high-sensitivity troponins (hsTns), creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), myoglobin, cardiac myosin-binding protein C and new cardiac biomarkers. This study evaluated the levels of serum thrombomodulin (TM), heart-type fatty-acid-binding protein (H-FABP), pentraxin-3 (PTX-3) and galectin-3 (Gal-3) to determine their utility in distinguishing between ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). Methods: This study included a total of 180 patients (90 patients with acute STEMI and 90 patients with NSTEMI) who presented to the Gaziosmanpa & scedil;a Training and Research Hospital, Cardiovascular Surgery and Emergency Department, with ischemic chest pain lasting longer than 30 min. Ninety healthy volunteers were included as the control group. Results: Serum levels of N-terminal pro-brain natriuretic peptide (NT-proBNP), TM, H-FABP, PTX-3 and Gal-3 were significantly different across the STEMI, NSTEMI and control groups (p < 0.001). Strong positive correlations were observed between NT-proBNP and TM, H-FABP, PTX-3 and Gal-3 in the STEMI group. ROC analysis demonstrated excellent diagnostic accuracy for these biomarkers in distinguishing STEMI from NSTEMI and control groups. Conclusions: Vascular inflammation plays an important role in the pathophysiology of STEMI and NSTEMI. A comprehensive cardiac biomarker panel enhances diagnostic accuracy and risk stratification, particularly when distinguishing between STEMI and NSTEMI. The biomarkers hs-TnI, CK-MB, NT-proBNP, TM, H-FABP, PTX-3 and Gal-3 offer complementary information when used together as a panel. Further research and validation are essential to establish standardized protocols for their widespread use.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.relation.isversionof10.3390/jcm14031015en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMyocardial infarctionen_US
dc.subjectSTEMIen_US
dc.subjectNSTEMIen_US
dc.subjectThrombomodulinen_US
dc.subjectHeart-type fatty-acid-binding proteinen_US
dc.titleEvaluation of Thrombomodulin, Heart-Type Fatty-Acid-Binding Protein, Pentraxin-3 and Galectin-3 Levels in Patients with Myocardial Infarction, with and Without ST Segment Elevationen_US
dc.typearticleen_US
dc.departmentİstanbul Atlas Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorUzun, Hafize
dc.identifier.volume14en_US
dc.identifier.issue3en_US
dc.relation.journalJOURNAL OF CLINICAL MEDICINEen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster